Module 2: Acalabrutinib for Hematologic Malignancies_Matthew Davids, MD, MMSc_Catherine Coombs, MD_Anthony Mato, MSCE

8:16

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia Similar Videos

Similar Videos

Module 4: Emerging BTK Inhibitors_Matthew Davids, MD, MMSc_Catherine Coombs, MD_Anthony Mato, MD, MSCE

12:02
Module 4_Practical Issues in CLL Care_Matthew Davids, MD, MMSc_Jeffrey Bubis, DO, FACOI, FACP_Divis Khaira, MD

10:33
Susan O’Brien, MD; University of California Irvine; #DDHO2022

20:24

ABOUT

Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.

The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.

CONNECT

support@bioascend.com

(888) 476-9129

980 North Michigan Avenue, Suite 1400, Chicago, IL 60611